Panbela Therapeutics, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q2 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Panbela Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2012 to Q2 2024.
  • Panbela Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $0.000.
  • Panbela Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$177K, a 18.1% increase year-over-year.
  • Panbela Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was -$186K, a 60.3% decline from 2022.
  • Panbela Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was -$116K, a 76.2% increase from 2021.
  • Panbela Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was -$488K, a 65.4% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$177K $0 +$147K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$324K -$138K -$138K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$186K -$20K -$7K -53.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 -$179K -$19K +$37K +66.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$216K -$147K -$129K -717% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$87K $0 +$29K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$116K -$13K -$237K -106% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $121K -$56K +$348K +86.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$227K -$18K +$174K +90.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$401K -$29K +$87K +75% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$488K $224K +$298K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$786K -$404K -$315K -354% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$471K -$192K -$152K -380% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$319K -$116K -$24K -26.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$295K -$74K +$10K +11.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 -$305K -$89K +$101K +53.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$406K -$40K +$30K +42.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$436K -$92K -$21K -29.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$415K -$84K +$8K +8.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 -$423K -$190K -$135K -245% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$288K -$70K +$9K +11.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 -$297K -$71K -$43K -154% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 -$254K -$92K -$17K -22.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-24
Q3 2018 -$237K -$55K +$142K +72.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$379K -$79K +$33K +29.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$412K -$28K +$124K +81.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$536K -$75K +$16K +17.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-22
Q3 2017 -$552K -$197K -$152K -338% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 -$400K -$112K -$22K -24.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$378K -$152K -$37K -32.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$341K -$91K +$547K +85.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-21
Q3 2016 -$888K -$45K -$22K -95.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$866K -$90K -$52K -137% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$814K -$115K -$58K -102% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$756K -$638K Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 -$23K -$19K -475% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$38K -$38.1K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$57K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q3 2014 -$4K -$4.22K -1918% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 $121* -$79 Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q4 2013 $220 -$400 Oct 1, 2013 Dec 31, 2013 10-K 2015-03-30
Q3 2013 $220 +$181 Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $200 +$203 Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-14
Q1 2013 $200 Jan 1, 2013 Mar 31, 2013 10-Q 2014-08-14
Q3 2012 $39.00* Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$3* Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.